SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

Andere talen Sihuan Pharmaceutical Holdings Group Ltd.

Aandelen

460 BMG8162K1137

Vertraagde tijd Hong Kong S.E. Andere beurzen 07:03:56 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,61 ^HKD	+7,02%		+19,61%	-6,15%

25/04	Sihuan Pharma eenheid wint offerte voor levering insulineproducten aan Chinese overheid	MT
29/03	Sihuan Pharmaceutical verkleint het verlies over 2023 door de afwezigheid van bijzondere waardeverminderingen op activa en investeringen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sihuan Pharma Unit Wins Bid to Supply Insulin Products to Chinese Government	25/04
Sihuan Pharmaceutical Narrows 2023 Loss on Absence of Asset, Investment Impairments	29/03
Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Sihuan Pharmaceutical's RF Device Wins Registration Approval in China	25/03
Sihuan Pharmaceutical Holdings Unit Forms Consortium for Ji Yao Restructuring	08/02
China Approves Drug Registration for Sihuan Pharmaceutical Unit's Type 2 Diabetes Drug	23/01
Sihuan Pharmaceutical Holdings Group Ltd. Receives Registration Approval from National Medical Products Administration for Proline Janagliflozin Tablets	22/01
China Includes Four Injectables by Sihuan Pharma Associate in Drug Reimbursement List; Shares Rise 3%	10/01
China Grants Registration Approval to Sihuan Pharmaceutical's Insulin Products	08/01
Sihuan Pharmaceutical Holdings Group Ltd. Obtains Drug Registration Approval from the National Medical Products Administration of the People's Republic of China for the Treatment of Diabetes	08/01
China's Medical Products Administrator Approves Sihuan Pharma Unit's Diabetes Drug	25-10-23
National Medical Products Administration Approves IND Application of Insulin Degludec and Liraglutide Injection, Developed by Huisheng Biopharmaceutical	25-10-23
China Accepts New Drug Application of Sihuan Pharmaceutical Subsidiary's Breast Cancer Treatment	17-10-23
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023	13-10-23
China Accepts New Drug Application for Sihuan Pharmaceutical Unit's Breast Cancer Tablets	05-09-23
Sihuan Pharmaceutical Swings to H1 Loss	29-08-23
Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Sihuan Pharmaceutical's Revenue to Drop 30% in H1	03-08-23
Sihuan Pharmaceutical Holdings Group Ltd. Provides Unaudited Consolidated Guidance for the Six Months Ended 30 June 2023	02-08-23
China Approves Sihuan Unit's Clinical Trial for Diabetes Injections; Shares Fall 3%	06-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sihuan Pharmaceutical Holdings Group Ltd.

Aandelen

460

BMG8162K1137

Andere talen

Filters